Close Menu

NEW YORK – FindGene Clinical Laboratories of China said last week that the country's National Medical Products Administration (NMPA) has approved its noninvasive prenatal screening test kit for in vitro diagnostic use.

The sequencing-based test screens for fetal trisomies 21, 18, and 13 using cell-free DNA from maternal blood. It relies on reversible terminator technology optimized by FindGene, which the company said provides "unprecedented accuracy."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.